ADDITIONAL EVIDENCE FOR THE AUGMENTED INDUCTION OF TUMOR-SPECIFIC RESISTANCE IN VACCINIA VIRUS-PRIMED MICE BY IMMUNIZATION WITH VACCINIA VIRUS-MODULATED SYNGENEIC TUMOR-CELLS

被引：0

作者：

UEDA, S ^{[1
]}

WAKAMIYA, N ^{[1
]}

WU, KS ^{[1
]}

KATO, S ^{[1
]}

FUJIWARA, H ^{[1
]}

HAMAOKA, T ^{[1
]}

机构：

[1] OSAKA UNIV,SCH MED,INST CANC RES,DEPT ONCOGENESIS,FUKUSHIMA KU,OSAKA 553,JAPAN

来源：

BIKEN JOURNAL | 1984年 / 27卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1 / 7

页数：7

共 50 条

[21] Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice
Gnant, MFX
Puhlmann, M
Alexander, HR
Bartlett, DL
CANCER RESEARCH, 1999, 59 (14) : 3396 - 3403
[22] Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cells induces tumor-specific cytotoxic T cells in mice
Yamamoto, S
Suzuki, S
Hoshino, A
Akimoto, M
Shimada, T
CANCER GENE THERAPY, 1997, 4 (02) : 91 - 96
[23] Sensitization of tumor necrosis factor α-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus
Gnant, MFX
Berger, AC
Huang, J
Puhlmann, M
Wu, PC
Merino, MJ
Bartlett, DL
Alexander, HR
Libutti, SK
CANCER RESEARCH, 1999, 59 (18) : 4668 - 4674
[24] EXPRESSION OF VACCINIA VIRUS EARLY MESSENGER-RNA IN EHRLICH ASCITES TUMOR-CELLS .2. PART OF THE POLYSOMES AT AN EARLY STAGE OF VIRUS-INFECTION ARE NOT BOUND TO THE CYTOSKELETON
LEMIEUX, R
BEAUD, G
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1982, 129 (02): : 273 - 279
[25] Immunization with a syngeneic tumor infected with recombinant vaccinia virus expressing granulocyte-macrophage colony-stimulating factor (GM-CSF) induces tumor regression and long-lasting systemic immunity
McLaughlin, JP
Abrams, S
Kantor, J
Dobrzanski, MJ
Greenbaum, J
Schlom, J
Greiner, JW
JOURNAL OF IMMUNOTHERAPY, 1997, 20 (06): : 449 - 459
[26] INDUCTION OF TRANSPLANTATION RESISTANCE WITH SOLUBLE SIMIAN-VIRUS 40-INDUCED HAMSTER TUMOR-SPECIFIC TRANSPLANTATION ANTIGEN
COGGIN, JH
CANCER RESEARCH, 1979, 39 (08) : 2952 - 2959
[27] Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen
Xie, YC
Hwang, C
Overwijk, W
Zeng, Z
Eng, MH
Mulé, JJ
Imperiale, MJ
Restifo, NP
Sanda, MG
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (02): : 169 - 175
[28] TNF-Mediated toxicity after massive induction of specific CD8+ T cells following immunization of mice with a tumor-specific peptide
Bilsborough, J
Uyttenhove, C
Colau, D
Bousso, P
Libert, C
Weynand, B
Boon, T
Van den Eynde, BJ
JOURNAL OF IMMUNOLOGY, 2002, 169 (06): : 3053 - 3060
[29] Induction of anti-tumor immunity elicited by tumor cells expressing a murine LFA-3 analog via a recombinant vaccinia virus (vol 10, pg 623, 1999)
Lorenz, MGO
Kantor, JA
Schlom, J
Hodge, JW
HUMAN GENE THERAPY, 1999, 10 (07) : 1260 - 1260
[30] INFECTION OF DBA/2 OR C3H-HEJ MICE BY INTRAPERITONEAL INJECTION OF VACCINIA VIRUS ELICITS ACTIVATED MACROPHAGES, CYTOLYTIC AND CYTOSTATIC FOR S91-MELANOMA TUMOR-CELLS
NATUK, RJ
BYRNE, JA
HOLOWCZAK, JA
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1986, 22 (03) : 197 - 203

← 1 2 3 4 5 →